What we do
We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We have a significant global presence with commercial operations in more than 150 countries, a network of 89 manufacturing sites, and large R&D centres in the UK, USA, Belgium and China. In Nigeria, our commercial office is located in Ilupeju, Lagos, and the manufacturing site in Agbara, Ogun State.
Our Consumer Healthcare business develops and markets products in Pain relief, Oral health, Nutrition and Digestive health. It has a portfolio of some of the world’s most trusted and best selling brands which includes Sensodyne, Voltaren, Horlicks and Panadol.
We are one of the world’s leading over-the-counter (OTC) medicines company. We hold number one positions in OTC medicines across 36 markets, and are market leaders in specialist oral care.
We have a portfolio of loved and trusted brands that are underpinned by science including: Sensodyne, Andrews ,Voltaren, Panadol, Otrivin and Horlicks.
Today, people are taking an increasingly active role in managing their own health. This is being fuelled by an emerging global middle class, rising healthcare costs and ageing populations. Demand for consumer healthcare products is growing, particularly in emerging markets (like Nigeria) where consumers are seeking more affordable and accessible products.
Consumer healthcare products are dependent on brand loyalty and trademark protection. Some of our heritage brands such as Macleans and Andrews continue to be popular household names today.
Our strategy is to combine the best of our pharmaceutical and Fast Moving Consumer Goods (FMCG) capabilities to become the first and best Fast Moving Consumer Healthcare Company driven by science and values.
To do this we are focused on building strong global brands, relentless innovation, best in class interactions with retailers, healthcare professionals and shoppers, the highest quality products at the right time and cost, and talented committed people.
Research for product innovation
Our business is built on science and this research heritage contributes to the development of our Consumer Healthcare products, giving us a unique advantage over our competition.
Today, we are using science to speed up the time to develop new product innovations, make them more accessible to the people who need them, and to develop benefits our consumers’ value, ultimately growing our business.
At the same time, we continue to ensure we meet all regulatory requirements for testing, approval, manufacturing, labelling and marketing of our products.
You can find out more about our R&D work on Consumer Healthcare products in our Research section.
Pharmaceuticals and Vaccines
Our Pharmaceuticals business discovers, develops and makes medicines to treat a broad range of the world's most common acute and chronic diseases.
Our strategy is to bring more medicines of value to more people who need them working in partnership with governments, NGOs and academia . We will do this by building an integrated and local healthcare company with the capabilities, people and portfolio to reach more patients and consumers in the Nigeria than ever before.
In Nigeria, our business is made up of innovative and established medicines, and holds leading positions in Respiratory, Vaccines and Anti-infectives portfolios among others. Our Global Pharmaceuticals R&D organization drives the discovery and development in several core areas of research: HIV and infectious diseases, oncology, immuno-inflammation, respiratory and rare diseases.
Click to find more about our prescription medicines and vaccines in Nigeria.
Global Manufacturing and Supply (GMS)
GMS is the manufacturing unit of GSK Consumer Nigeria Plc. It is located in Agbara, Ogun State. Because we are committed to continuous improvement in our manufacturing operations, we have continued to advance our commitment to fully satisfy industry standards and regulatory expectations. We continue to ensure that our factory consistently complies with these requirements to facilitate state-of-the-art upgrades. GMS caters for almost all the products within the stable of the Consumer division of the business.
With huge investments in capital projects aimed at multiplying our current production capabilities, GMS is set to be a strong driver of the business goals. The Site provides for the Nigerian market, and just recently commenced export into Ghana.
In line with our commitment to improving the quality of human life by enabling people to do more, feel better and live longer, we offer career opportunities in functions within our organisation. We place strong focus on our people, because we believe that they are the key drivers of our business growth.